These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16135911)

  • 1. Bradycardia-tachycardia syndrome induced by lopinavir-ritonavir in a patient with AIDS.
    Yotsumoto M; Kitano K; Saito H
    AIDS; 2005 Sep; 19(14):1547-8. PubMed ID: 16135911
    [No Abstract]   [Full Text] [Related]  

  • 2. Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome.
    Kikuchi Y; Genka I; Ishizaki A; Sunagawa K; Yasuoka A; Oka S
    Clin Infect Dis; 2002 Aug; 35(4):488-90. PubMed ID: 12145735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme bradycardia due to multiple drug-drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir-ritonavir.
    Puech R; Gagnieu MC; Planus C; Charpiat B; Boibieux A; Ferry T; Tod M
    Br J Clin Pharmacol; 2011 Apr; 71(4):621-3. PubMed ID: 21395657
    [No Abstract]   [Full Text] [Related]  

  • 4. Stavudine-induced pancreatitis followed by lopinavir-ritonavir-induced pancreatitis.
    Anand H; Parthasarathi G; Ramesh M
    J Postgrad Med; 2008; 54(2):153-5. PubMed ID: 18480538
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complete auriculoventricular block in a patient treatment with Lopinavir/Ritonavir].
    Jiménez FJ; Pinilla J; Repiso M; Labarga P
    Enferm Infecc Microbiol Clin; 2002 Oct; 20(8):418. PubMed ID: 12372245
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between lopinavir/ritonavir and warfarin.
    Hughes CA; Freitas A; Miedzinski LJ
    CMAJ; 2007 Aug; 177(4):357-9. PubMed ID: 17698824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lopinavir-ritonavir (Kaletra) and lithiasis: seven cases.
    Doco-Lecompte T; Garrec A; Thomas L; Trechot P; May T; Rabaud C
    AIDS; 2004 Mar; 18(4):705-6. PubMed ID: 15090783
    [No Abstract]   [Full Text] [Related]  

  • 8. Lopinavir + ritonavir tablets: new formulation. More convenient, but minimal evaluation.
    Prescrire Int; 2007 Aug; 16(90):148. PubMed ID: 17724839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
    Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ
    J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy.
    McArthur MA; Kalu SU; Foulks AR; Aly AM; Jain SK; Patel JA
    Pediatr Infect Dis J; 2009 Dec; 28(12):1127-9. PubMed ID: 19820426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.
    Cameron DW; da Silva BA; Arribas JR; Myers RA; Bellos NC; Gilmore N; King MS; Bernstein BM; Brun SC; Hanna GJ
    J Infect Dis; 2008 Jul; 198(2):234-40. PubMed ID: 18540803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lopinavir/ritonavir in pregnancy.
    Roberts SS; Martinez M; Covington DL; Rode RA; Pasley MV; Woodward WC
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):456-61. PubMed ID: 19381099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maculo-papular rash induced by lopinavir/ritonavir.
    Calista D
    Eur J Dermatol; 2005; 15(2):97-8. PubMed ID: 15757820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encouraging resistance data for Kaletra (lopinavir/ritonavir).
    J Assoc Nurses AIDS Care; 2002; 13(3):108. PubMed ID: 12064017
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.
    Hussain S; Khayat A; Tolaymat A; Rathore MH
    Pediatr Nephrol; 2006 Jul; 21(7):1034-6. PubMed ID: 16773419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lopinavir + ritonavir oral solution: dangerous form for newborns.
    Prescrire Int; 2011 Oct; 20(120):237. PubMed ID: 21970085
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protease inhibitor Kaletra (Lopinavir/Ritonavir): significance and role in antiretroviral therapy of HIV infection and AIDS].
    Galegov GA
    Antibiot Khimioter; 2007; 52(1-2):42-5. PubMed ID: 18461809
    [No Abstract]   [Full Text] [Related]  

  • 18. Hair loss induced by lopinavir-ritonavir.
    Borrás-Blasco J; Belda A; Rosique-Robles D; Casterá E; Abad J; Amorós-Quiles I
    Pharmacotherapy; 2007 Aug; 27(8):1215-8. PubMed ID: 17655521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of a large randomized study: after switch to LPV/r quality of life improved].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():49. PubMed ID: 15011589
    [No Abstract]   [Full Text] [Related]  

  • 20. Sinus bradycardia induced by darunavir-ritonavir in a patient with acquired immunodeficiency syndrome.
    Gonzales Zamora JA; Espinoza LA
    Infection; 2017 Oct; 45(5):721-723. PubMed ID: 28865059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.